2 Monster Growth Stocks with Huge Potential in 2024 by Mark Eisenberg 08.04.2024 Consider investing in AbbVie and e.l.f., two names with significant growth potential in 2024. AbbVie shines as a quality business ...
Ventyx Biosciences: Financial Report Reveals Growth Challenges by Terry Bingman 28.03.2024 Ventyx Biosciences, Inc. (VTYX) is a high-risk investment with negative net income and high debt ratio, but analysts recommend buying ...
Connect Biopharma Welcomes James Huang: Growth Surge Ahead by Mark Eisenberg 13.02.2024 Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...